MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,818.93
+0.58%
NASDAQ 100
$31,224.47
+0.48%
DOW JONES
$51,521.00
+0.49%
NASDAQ Composite
$27,599.79
+0.45%
RUSSELL 2000
$2,813.40
-0.72%
CBOE VIX
$15.01
-3.29%
Sector Heatmap
Technology+0.53%
Financials+0.24%
Healthcare-0.17%
Consumer Cycl+1.20%
Consumer Staples+0.90%
Energy+0.47%
Industrials+0.87%
Materials+0.46%
Real Estate+1.06%
Utilities+2.98%
Comm Services+0.04%
MRK — Merck & Co., Inc.
NYSEMerck & Co., Inc.
$141.94
+2.40(+1.72%)
- O
- 140.13
- H
- 142.16
- L
- 139.74
- V
- 8.05M
⏱️ End-of-day dataAs of Oct 6, 2026
Chart
About MRK
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. In cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 53% of the company's 2025 sales were generated from US human health (pharmaceuticals and vaccines).
IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateApr 20, 1949
Employees75,000
Stock ExchangeNYSE
Ticker SymbolMRK
Websitehttps://www.merck.com
Key Financial Statistics
| Market Cap | $356.01B |
| P/E Ratio | N/A |
| Dividend Yield | 2.40% (Quarterly) |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $82.01 - $156.92 |
| 52-Week Avg Volume | 11.24M |
| VWAP | $141.34 |
| Transactions | 101,984 |
| Total Recorded Bars | 14,311 days |